Home » People » interviews
India should focus on pharma intermediates self-sufficiency : A column by Dr. K. Nagaiah,Chief Scientist & Head - Centre for Natural Product and Traditional Knowledge, CSIR-IICT, Hyderabad

India should focus on pharma intermediates self-sufficiency : A column by Dr. K. Nagaiah,Chief Scientist & Head - Centre for Natural Product and Traditional Knowledge, CSIR-IICT, Hyderabad

India’s dependency on China for pharma intermediates can change if there is a proper coordination between educational institutes, research institutes and pharma manufacturers

We plan to invest Rs. 1,000 Cr in the next 3 to 4 years : Priyanka Chigurupati, Executive Director, Granules Pharmaceuticals

We plan to invest Rs. 1,000 Cr in the next 3 to 4 years : Priyanka Chigurupati, Executive Director, Granules Pharmaceuticals

India is dependent upon China and other countries for a lot of Key Starting Materials (KSM) for their bulk drug needs.

Startup

DPIIT and Thermo Fisher Scientific launch BioVerse challenge to fast-track India’s biotech future
DPIIT and Thermo Fisher Scientific launch BioVerse challenge to fast-track India’s biotech future
Lilly opens biotech in San Diego
Lilly opens biotech in San Diego
Bayer launches biotech innovation platform in China
Bayer launches biotech innovation platform in China
View More

Digitization

IKS Health announces generative AI platform built on Google cloud
IKS Health announces generative AI platform built on Google cloud
Well Pharmacy onboards Datamatics to automate medication record management
Well Pharmacy onboards Datamatics to automate medication record management
Roche’s AI-based kidney disease algorithm gains European certification
Roche’s AI-based kidney disease algorithm gains European certification
View More

Latest Stories

Strides partners with Incepta to expand women's health access with WHO-prequalified contraceptive

Indegene strengthens consulting practice to accelerate life sciences transformation

IKS Health announces generative AI platform built on Google cloud

Novelix signs technology transfer agreement with Germany-based GMBU for production of Astaxanthin

Biocon Biologics and Civica launch private-label Insulin glargine

Opinion
Metal-free catalysis is transforming future of sustainable pharmaceutical innovation
Metal-free catalysis is transforming future of sustainable pharmaceutical innovation
From Policy to Practice: How India’s Pharmaceutical Industry is Being Shaped by the PLI Scheme – by Vikram Aditya Sehgal, Director – Finance, Centrient India
From Policy to Practice: How India’s Pharmaceutical Industry is Being Shaped by the PLI Scheme – by Vikram Aditya Sehgal, Director – Finance, Centrient India

Interviews
India remains a very important part of our ecosystem: Vaios Barlas, Global Director Healthcare, Clariant and Bhushan Thekedar, Head of Global Business Development Healthcare, Clariant
India remains a very important part of our ecosystem: Vaios Barlas, Global Director Healthcare, Clariant and Bhushan Thekedar, Head of Global Business Development Healthcare, Clariant
Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India
Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India
Dr. R. Ananthanarayanan CEO, Sajjan India
Our focus is on organic expansion and building our own plants...: Dr. Aman Desai, Promoter and Whole Time Director, Aether Industries
Our focus is on organic expansion and building our own plants...: Dr. Aman Desai, Promoter and Whole Time Director, Aether Industries
Dr. Aman Desai Promoter and Whole Time Director, Aether Industries

Packaging